{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:56:20Z","timestamp":1780469780025,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.atherosclerosis.2011.11.037","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T21:58:24Z","timestamp":1323381504000},"page":"456-462","source":"Crossref","is-referenced-by-count":28,"title":["KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly"],"prefix":"10.1016","volume":"220","author":[{"given":"Hironobu","family":"Akao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Polisecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Kajinami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Trompet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J.M.","family":"de Craen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi G.J.","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Packard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.298.7.776","article-title":"Clinical utility of different lipid measures for prediction of coronary heart disease in men and women","volume":"298","author":"Ingelsson","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0010","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0015","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/GIM.0b013e318156fb62","article-title":"Five common gene variants identify elevated genetic risk for coronary heart disease","volume":"9","author":"Bare","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jacc.2007.09.044","article-title":"A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study","volume":"51","author":"Shiffman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/ATVBAHA.107.153981","article-title":"Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study","volume":"28","author":"Shiffman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0030","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jacc.2010.06.022","article-title":"Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case\u2013control studies","volume":"56","author":"Assimes","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jacc.2007.05.057","article-title":"Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials","volume":"51","author":"Iakoubova","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0040","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.amjcard.2009.12.049","article-title":"Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial","volume":"105","author":"Shiffman","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0045","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jacc.2007.10.017","article-title":"Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study","volume":"51","author":"Iakoubova","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/HJR.0b013e328336a0dd","article-title":"KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study","volume":"17","author":"Iakoubova","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0055","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2011.02.015","article-title":"No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study","volume":"57","author":"Hopewell","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0060","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCGENETICS.110.959353","article-title":"Kinesin-like protein 6 (KIF6) Polymorphism and the efficacy of rosuvastatin in primary prevention","volume":"4","author":"Ridker","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0065","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"PROspective study of pravastatin in the elderly at risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0070","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0002-9149(99)00533-0","article-title":"The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk","volume":"84","author":"Shepherd","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-2275(20)38697-1","article-title":"A rapid micromethod for apolipoprotein E phenotyping directly in serum","volume":"28","author":"Havekes","year":"1987","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0080","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/clinchem\/42.11.1817","article-title":"Frequency of phenotype\u2013genotype discrepancies at the apolipoprotein E locus in a large population study","volume":"42","author":"Lahoz","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0021-9150(94)05439-P","article-title":"Effect of apolipoprotein E and A\u2013IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy","volume":"113","author":"Ordovas","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9150(01)00410-5","article-title":"Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner","volume":"158","author":"Pedro-Botet","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0095","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.ATV.16.10.1250","article-title":"Apolipoprotein E alleles and risk of coronary disease: a meta-analysis","volume":"16","author":"Wilson","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0021-9150(00)00570-0","article-title":"Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study","volume":"154","author":"Lahoz","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/genetics\/50.4.757","article-title":"The interaction of selection and linkage. II. Optimum models","volume":"50","author":"Lewontin","year":"1964","journal-title":"Genetics"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0110","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2007.12.004","article-title":"Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER","volume":"200","author":"Polisecki","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2007.12.005","article-title":"Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population","volume":"200","author":"Polisecki","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.11.037_bib0125","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1194\/jlr.P001172","article-title":"Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly","volume":"51","author":"Polisecki","year":"2010","journal-title":"J Lipid Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011011087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011011087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T13:10:48Z","timestamp":1639919448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011011087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0021915011011087"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.11.037","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}